Fundz
Real-time · AI · Cross-signal

Discover the power of real-time signals plus AI

Every contract, funding round, exec hire, and M&A move on BGM Group Ltd — with verified, ICP-scored contact reveals (email + mobile) on demand.

Trusted by founders, sales teams, recruiters, and investors at firms like BlackRock, Oracle, Kleiner Perkins, and HubSpot.

See plansBook a 15-min walkthrough
Watch the 2-minute tour · with sound

AIX and BGM Group Enter Strategic Transaction Agreement for Equity Interests Transfer and Share Acquisition

Nov 29, 2024over 1 year ago

Contract Type

agreement

ChengduBiotechnologyArtificial IntelligencePharmaceutical

Description

AIX Inc. has entered into a strategic transaction agreement with BGM Group Ltd., involving the transfer of the equity interests of RONS Intelligent Technology (Beijing) Co., Ltd. and Shenzhen Xinbao Investment Management Co., Ltd., valued at approximately US$140.0 million, to BGM in exchange for 69,995,661 of BGM’s Class A ordinary shares. This agreement is expected to lead to enhanced development opportunities and growth potential for both RONS Technology and Xinbao Investment, as well as accelerate AIX’s strategic expansion into the pharmaceutical and healthcare sector.

Company Information

Company

BGM Group Ltd

Location

Chengdu, Sichuan, China

About

BGM Group Ltd is a leading global pharmaceutical enterprise with a focus on biopharmaceuticals. With this acquisition, BGM is venturing into AI intelligent technology and financial and insurance services, expanding its business beyond biopharmaceuticals and initiating a new era in the digital and intelligent landscape.

Predictive Intelligence
Strategic

ML-powered predictions for BGM Group Ltd's next move

Learn about Strategic plan

Related People

Suggested for you

Sign in to view contact details

Agreement Insights

Based on industry data
Contract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months